-
2023-505483-11-00
6
2021-05-02
Brain abscess
-
2023-508722-99-00
4
2020-11-19
Vulvar cancer
-
2024-510579-40-00
9
2020-10-07
Rhabdoyosarcoma
-
2022-501456-28-00
5
2020-07-20
atypical teratoid/rhabdoid tumours (ATRT)
-
2022-501050-11-01
10
2020-07-13
Acute Lymphoblastic Leukaemia
-
2024-511053-22-00
4
2020-05-04
Primary sclerosing cholangitis (PSC)
-
2022-501454-11-00
5
2020-02-05
standard risk ALK-positive anaplastic large cell lymphoma (ALCL)
-
2023-508101-24-00
5
2019-08-01
Lymphoblastic lymphoma
-
2023-505934-86-00
6
2019-03-26
Obesity
-
2023-504917-54-00
5
2018-10-30
Biochemical recurrence after prostate cancer surgery
-
2022-501254-10-00
5
2018-08-24
Advanced tumors
-
2024-517719-65-00
4
2017-02-01
Resectable pancreatic head cancer
-
2024-515626-92-00
4
2013-10-18
recurrent/progressive medulloblastoma, ependymoma and atypical teratoi
-
2024-518254-16-00
5
2013-03-01
Acute Myeloid Leukemia (Pediatric 0-18 years)
-
2024-512720-11-00
5
2025-01-16
chronic venous ulcers (CVU)
-
2024-518669-83-00
4
2024-12-05
acute promyelocytic leukemia (APL) in children and adolescents
-
2024-513539-25-00
4
2024-11-22
Type 2 Diabetes Mellitus
-
2024-512676-36-00
10
2024-10-09
Langerhans Cell Histiocytosis
-
2022-501176-26-00
5
2023-08-04
Acute Ischemic Stroke and High-Risk Transient Ischemic Attack
-
2022-502922-41-00
5
2023-07-03
Obesity and overweight
-
2024-510742-13-00
5
2023-04-19
Pediatric low-grade glioma harboring an activating RAF alteration requ
-
2023-508588-58-00
4
2022-10-25
Diabetes type 1
-
2023-505318-97-00
5
2022-09-22
Retinopathy of Prematurity
-
2023-509864-96-00
4
2021-12-07
Mantle Cell Lymphoma (MCL)